Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 11Motor Activity 3Osteoporosis 2Neoplasms 2Urinary Incontinence 1Urinary Bladder Neoplasms 1Stroke 1Signs and Symptoms 1Sarcopenia 1Rectal Neoplasms 1Pelvic Floor Disorders 1Obesity 1Neoplasm Metastasis 1Kidney Diseases 1Hypertension 1Heart Failure 1Head and Neck Neoplasms 1Frailty 1Diabetes Mellitus 1Colorectal Neoplasms 1Cardiovascular Diseases 1Carcinoma, Transitional Cell 1Arthritis 1

Interventions

pembrolizumab 92Gemcitabine 56Nivolumab 50Cisplatin 39atezolizumab 37Carboplatin 30avelumab 29enfortumab vedotin 26Docetaxel 23Magnetic Resonance Spectroscopy 19Mitomycin 17Ipilimumab 17Paclitaxel 16Specimen Handling 14durvalumab 11toripalimab 10sacituzumab govitecan 10Pemetrexed 10cabozantinib 9Taxes 8vinflunine 7Cyclophosphamide 7tislelizumab 6Injections 6Bevacizumab 6pemigatinib 5fludarabine 5disitamab vedotin 5Standard of Care 5Radiosurgery 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Transitional Cell × Resistance Training × Genitourinary × Clear all
NCT04223063 2020-01-10

Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study

Nova Scotia Health Authority

Phase NA Unknown
20 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡